Publication
Oncologic Outcomes in a Contemporary "PROTEUS-like" Cohort of High-risk Prostate Cancer Treated with Radical Prostatectomy Without Neoadjuvant Hormonal Therapy.
Can Aydogdu, Benso John, Clara Seizer, Frederik Kolligs, Iason Papadopoulos, Alexander Buchner, Elena K Berg, Jozefina Casuscelli, Julie Steinestel, Roman Mayr, Matthias Heck, Christian G Stief, Thilo Westhofen
- Source
- PubMed
- Retrieved
- Sep 19, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260919-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
BACKGROUND AND OBJECTIVE: High-risk prostate cancer (PCa) carries substantial risks of recurrence, metastasis, and mortality. Neoadjuvant therapy before radical prostatectomy (RP) remains investigational. The PROTEUS (NCT03767244) trial evaluates perioperative apalutamide + androgen deprivation…
Read on PubMedLinked entities
Linked entities (2)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Validated 1
- trialNCT03767244registry_reference1.00
Candidate 1
- cancerMalignant Prostate Neoplasmdictionary0.60
Registered trialsNCT03767244
Curated evidence
Evidence citing this paper (0)
Data not yet available